Expert Interview
A look at potential therapies in essential tremor, including PRAX-944 (T-type calcium channel blocker) and Suvecaltamide
Ticker(s): PRAX, JAZZInstitution: Houston Methodist
- Professor of Neurology, Methodist Research Institute & Weill Cornell Medical School; Director, Movement Disorders Clinic, Methodist Neurological Institute; Director, Restless Legs Syndrome Quality Care Center.
- Treats > 350 patients with Parkinson's Disease
- Has participated in over 100 clinical trials for PD; GOCOVRI prescriber and has used INBRIJA in trials.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
